Measuring bioavailability, utilization, and excretion of rumen-protected lysine in lactating cows using an isotope technique

Supplementing a diet with rumen-protected amino acids (AAs) is a common feeding strategy for efficient production. For a cost-effective use of rumen-protected AA, the accurate bioavailability of rumen-protected amino acids should be known and their metabolism after absorption needs to be well understood. The current study determined the bioavailability, absorption, utilization, and excretion of rumen-protected Lys (RP-Lys). Four ruminally cannulated cows in a 4 × 4 Latin square design (12 d for diet adaptation; 5 or 6 d for total collections) received the following treatments: L0, a basal diet; L25, the basal diet and L-Lys infused into the abomasum to provide 25.9 g/d L-Lys; L50, the basal diet and L-Lys infused into the abomasum to provide 51.8 g/d L-Lys; and RPL, the basal diet supplemented with 105 g/d (as-is) of RP-Lys to provide 26.7 g of digestible Lys. During the last 5 or 6 d in each period, 15N-Lys (0.38 g/d) was infused into the abomasum for all cows to label the pool of AA, and the total collection of milk, urine, and feces were conducted. 15N enrichment of samples on d 4 and 5 were used to calculate the bioavailability and Lys metabolism. We used a model containing a fast AA turnover (≤ 5 d) and slow AA turnover pool (> 5 d) to calculate fluxes of Lys. The Lys flux to the fast AA turnover pool (absorbed Lys + Lys from the slow AA turnover pool to fast AA turnover pool) was calculated using 15N enrichment of milk Lys. The flux of Lys from the fast AA turnover pool to milk and urine was calculated using 15N transfer into milk and urine. Then, absorbed Lys was estimated by the sum of Lys flux to milk and urine assuming no net utilization of Lys by body tissues. Duodenal Lys flow was estimated by 15N enrichment of fecal Lys. The bioavailability of RP-Lys was calculated from duodenal Lys flows and Lys absorption for RPL. Increasing Lys supply from L25 to L50 increased Lys utilization for milk by 9 g/d but also increased urinary excretion by 10 g/d. For RPL, absorbed Lys was estimated to be 136 g/d where 28 g of absorbed Lys originated from RP-Lys. In conclusion, 68% of bioavailability was obtained for RP-Lys. The Lys provided from RP-Lys was not only utilized for milk protein (48%) but also excreted in urine (20%) after oxidation.

Availability to lactating dairy cows of methionine added to soy lecithins and mixed with a mechanically extracted soybean meal

We evaluated a product containing methionine mixed with soy lecithins and added to a mechanically extracted soybean meal (meSBM-Met). Lactational responses of cows, plasma methionine concentrations, and in vitro degradation of methionine were measured. Twenty-five Holstein cows were used in a replicated 5 × 5 Latin square design and fed a diet designed to be deficient in methionine or the same diet supplemented either with 4.2 or 8.3g/d of supplemental methionine from a ruminally protected source or with 2.7 or 5.3g/d of supplemental methionine from meSBM-Met. All diets were formulated to provide adequate amounts of metabolizable lysine. Concentration of milk true protein was greater when methionine was provided by the ruminally protected methionine than by meSBM-Met, but milk protein yield was not affected by treatment. Milk yields and concentrations and yields of fat, lactose, solids-not-fat, and milk urea nitrogen were not affected by supplemental methionine. Body condition scores increased linearly when methionine from meSBM-Met was supplemented, but responses were quadratic when methionine was provided from a ruminally protected source. Nitrogen retention was not affected by supplemental methionine. Plasma methionine increased linearly when methionine was supplemented from a ruminally protected source, but plasma methionine concentrations did not differ from the control when supplemental methionine from meSBM-Met was provided. In vitro degradation of supplemental methionine from meSBM-Met was complete within 3h. Data suggest that meSBM-Met provides negligible amounts of metabolizable methionine to dairy cows, and this is likely related to extensive ruminal destruction of methionine; however, cow body condition may be improved by ruminally available methionine provided by meSBM-Met.